Homeostatic changes of the endocannabinoid system in Parkinson’s disease† Dr D Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis